Skip to main content
. 2017 Jan 13;24(4):697–708. doi: 10.1093/jamia/ocw168

Figure 3.

Figure 3.

Evaluation of the ROC curves of pharmacovigilance algorithms created by (A) MetaLAB (MLLRS, AUCs = 0.69 ± 0.11) and (B) MetaNurse (MNNRS, AUCs = 0.62 ± 0.07) against the extensive RS-ADR gold standard comprising 117 and 757 MedDRA PTs, respectively, for 101 precautionary drugs. ROC curves for the 10 drugs reported by Yoon et al.13 for MetaLAB analysis against 11 817 drug-ADR pairs are presented as colored curves.